|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A Prospective, Randomized, Double-blinded, Active-control, 3-Treatment Arm, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of On-demand Therapy with CDFR0812-15/50mg Compared to On-demand Therapy with Single-drug Administration of Clomipramine HCl 15mg or Sildenafil citrate 50mg in Male Patients Diagnosed with Premature Ejaculation
A Prospective, Randomized, Double-blinded, Active-control, 3-Treatment Arm, Parallel, Multi-center, Phase 2 Trial to Evaluate Safety and Efficacy With CDFR0812-15/25mg and CDFR0812-15/50mg Compared to Clomipramine HCl 15mg in Male Patients Diagnosed With Premature Ejaculation
The purpose of this study is to evaluate the safety and efficacy of on-demand therapy with CDFR0812-15/25mg and CDFR0812-15/50mg compared to on-demand therapy with single-drug administration of Clomipramine HCl 15mg in Korean Male Patients Diagnosed with Premature Ejaculation
100 项与 PDE5A x SERT x NET 相关的临床结果
100 项与 PDE5A x SERT x NET 相关的转化医学
0 项与 PDE5A x SERT x NET 相关的专利(医药)